1. Wang, Guisheng, Hua, Rongrong, Chen, Xiaoxia, Zhao, Yu Qiong, Qiao, Li. 2024. MX1 and UBE2L6 are potential metaflammation gene targets in both diabetes and atherosclerosis. In PeerJ, 12, e16975. doi:10.7717/peerj.16975. https://pubmed.ncbi.nlm.nih.gov/38406276/
2. Orfali, Nina, Shan-Krauer, Deborah, O'Donovan, Tracey R, Tschan, Mario P, McKenna, Sharon L. 2020. Inhibition of UBE2L6 attenuates ISGylation and impedes ATRA-induced differentiation of leukemic cells. In Molecular oncology, 14, 1297-1309. doi:10.1002/1878-0261.12614. https://pubmed.ncbi.nlm.nih.gov/31820845/
3. Murakami, Midori, Izumi, Hiroto, Kurita, Tomoko, Morimoto, Yasuo, Yoshino, Kiyoshi. . UBE2L6 is Involved in Cisplatin Resistance by Regulating the Transcription of ABCB6. In Anti-cancer agents in medicinal chemistry, 20, 1487-1496. doi:10.2174/1871520620666200424130934. https://pubmed.ncbi.nlm.nih.gov/32329696/
4. Gao, Jiao, Li, Chonghui, Li, Wenjing, Fu, Yurong, Yi, Zhengjun. 2021. Increased UBE2L6 regulated by type 1 interferon as potential marker in TB. In Journal of cellular and molecular medicine, 25, 11232-11243. doi:10.1111/jcmm.17046. https://pubmed.ncbi.nlm.nih.gov/34773365/
5. Cheng, Ying, Zhang, Man, Xu, Rong, Sun, Bei, Chen, Liming. 2024. p53 accelerates endothelial cell senescence in diabetic retinopathy by enhancing FoxO3a ubiquitylation and degradation via UBE2L6. In Experimental gerontology, 188, 112391. doi:10.1016/j.exger.2024.112391. https://pubmed.ncbi.nlm.nih.gov/38437929/
6. Falvey, Chloe M, O'Donovan, Tracey R, El-Mashed, Shereen, O'Reilly, Seamus, McKenna, Sharon L. . UBE2L6/UBCH8 and ISG15 attenuate autophagy in esophageal cancer cells. In Oncotarget, 8, 23479-23491. doi:10.18632/oncotarget.15182. https://pubmed.ncbi.nlm.nih.gov/28186990/
智鼠故事 
